Table 4 The effect of UFH for the thresholds: a paired t test
| Pre-therapy | p value | During therapy | p value | ||||
|---|---|---|---|---|---|---|---|
| Region |
UFH (+) (n = 30) |
UFH (−) (n = 8) |
UFH (+) (n = 27) |
UFH (−) (n = 11) | |||
| SUVmean + 3SD | Liver 1 | 3.5 ± 0.4 | 3.6 ± 0.5 | 0.29 | 3.9 ± 0.6 | 3.4 ± 0.5 | 0.03 |
| SUVmax | Liver 2 | 3.5 ± 0.4 | 3.6 ± 0.4 | 0.76 | 4.0 ± 0.6 | 3.5 ± 0.5 | 0.03 |
| DA | 2.2 ± 0.3 | 2.1 ± 0.3 | 0.76 | 2.3 ± 0.3 | 2.1 ± 0.3 | 0.09 | |
| SUVmean | Liver 2 | 2.7 ± 0.3 | 2.8 ± 0.4 | 0.23 | 3.1 ± 0.5 | 2.7 ± 0.4 | 0.03 |
| DA | 1.9 ± 0.3 | 1.9 ± 0.3 | 0.83 | 2.0 ± 0.3 | 1.8 ± 0.3 | 0.1 | |
| SUVpeak | Liver 2 | 3.0 ± 0.4 | 3.1 ± 0.4 | 0.61 | 3.5 ± 0.6 | 3.1 ± 0.5 | 0.03 |
| DA | 2.0 ± 0.3 | 1.9 ± 0.3 | 0.51 | 2.0 ± 0.3 | 1.9 ± 0.3 | 0.06 |
